MSA Safety (MSA) Reports Next Week: Wall Street Expects Earnings Growth
MSA Safety (MSA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tiziana Life Sciences to present Phase 2a MSA study at World Parkinson Congress
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said on Tuesday a late-breaking poster on its Phase 2a study of intranasal foralumab in Multiple System Atrophy (MSA) has been accepted for presentation at the World Parkinson Congress in Phoenix, Arizona in May 2026. The poster, titled “A Phase 2a Study of Intranasal Foralumab in Multiple System Atrophy,” will outline the design and rationale of the ongoing TILS-025 trial, the company said.
BLAQclouds, Inc. Announces Master Service Agreement (MSA) with Spritz to Accelerate Crypto Payment Utility
Robesonia, PA, March 12, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BLAQclouds, Inc. (OTC: BCDS) today announced a Master Service Agreement (MSA) with Spritz that is designed to significantly expand real-world utility across the BLAQclouds ecosystem.
MSA Safety Incorporated (MSA) Q4 2025 Earnings Call Transcript
MSA Safety Incorporated (MSA) Q4 2025 Earnings Call Transcript
MSA Safety (MSA) Reports Q4 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for MSA Safety (MSA) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
MSA Safety (MSA) Tops Q4 Earnings and Revenue Estimates
MSA Safety (MSA) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.25 per share a year ago.
Income Investors Can Sleep Well With MSA's Dividend Despite 2023 Cash Flow Scare
MSA Safety (NYSE: MSA) pays $2.08 per share annually, yielding 1.28%.
MSA Safety Incorporated (MSA) Presents at Baird 55th Annual Global Industrial Conference Transcript
MSA Safety Incorporated ( MSA ) Baird 55th Annual Global Industrial Conference November 12, 2025 8:55 AM EST Company Participants Steven Blanco - President, CEO & Director Julie Beck - SVP, CFO & Treasurer Conference Call Participants Robert Mason - Robert W. Baird & Co. Incorporated, Research Division Presentation Robert Mason Robert W.
MSA Safety (MSA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for MSA Safety (MSA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
MSA Safety Incorporated (MSA) Q3 2025 Earnings Call Transcript
MSA Safety Incorporated ( MSA ) Q3 2025 Earnings Call October 29, 2025 10:00 AM EDT Company Participants Lawrence De Maria - Executive Director of Investor Relations Steven Blanco - President, CEO & Director Julie Beck - SVP, CFO & Treasurer Conference Call Participants Robert Mason - Robert W. Baird & Co. Incorporated, Research Division Ross Sparenblek - William Blair & Company L.L.C.
MSA Safety (MSA) Beats Q3 Earnings and Revenue Estimates
MSA Safety (MSA) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.9 per share. This compares to earnings of $1.83 per share a year ago.
Tiziana Life Sciences doses first MSA patient in new trial – ICYMI
Tiziana Life Sciences Ltd (NASDAQ:TLSA) CEO Ivor Elrifi talked with Proactive about the company's latest milestone: dosing the first patient in its Phase 2a clinical trial targeting multiple system atrophy (MSA), a rare and fatal neurodegenerative condition with no approved treatment. Elrifi explained the trial involves the company's investigational monoclonal antibody, Foralumab, which is administered intranasally and aims to reduce neuroinflammation.
